LC Explorer About LC About PLGD-1 About RYPLAZIM Testing Resources

Examine Ligneous Conjunctivitis (LC)

Examine the most common symptom site of PLGD-1: the lining of the eyelids, or conjunctiva...See more

Case 1

Case 2

Case 3

Case 4

Case 1: Patient Information

Week 0

10 x 2 mm lesion (right eye lower eyelid) at baseline

Week W 0

Week W 4

Week W 8

Week W 12

Week W 120

39 yr-old female - Baseline PLG activity 29%

Ocular manifestations

Left eye - 10 mm X 2 mm
Right eye - 10 mm X 2 mm

Prior treatments of disease

Surgery - Removal of pseudomembranes

Additional systemic manifestations

Cervix - Not Assessed
Right ear - Not Assessed

Results may vary

Onset

Advanced

RYPLAZIM® (plasminogen, human-tvmh) is a plasma-derived human plasminogen indicated for the treatment of patients with plasminogen deficiency type 1 (hypoplasminogenemia).